1-20 of 27
Wei Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma

Brian Mooney, Gian Luca Negri, Taras Shyp, Alberto Delaidelli, Hai-Feng Zhang, Sandra E. Spencer Miko, Amber K. Weiner, Alexander B. Radaoui, Rawan Shraim, Michael M. Lizardo, Christopher S. Hughes, Amy Li, Amal M. El-Naggar, Melanie Rouleau, Wei Li, Dimiter S. Dimitrov, Raushan T. Kurmasheva, Peter J. Houghton, Sharon J. Diskin, John M. Maris, Gregg B. Morin, Poul H. Sorensen
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (5): 1022–1037.
https://doi.org/10.1158/1078-0432.CCR-23-2187
Published: 01 March 2024
View article titled, Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma
Open the PDF for Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma in another window
Includes: Supplementary data
Journal Articles

Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Manish A. Shah, Kohei Shitara, Florian Lordick, Yung-Jue Bang, Niall C. Tebbutt, Jean-Phillippe Metges, Kei Muro, Keun-Wook Lee, Lin Shen, Sergei Tjulandin, John L. Hays, Naureen Starling, Rui-Hua Xu, Keren Sturtz, Marilyn Fontaine, Cindy Oh, Emily M. Brooks, Bo Xu, Wei Li, Chiang J. Li, Laura Borodyansky, Eric Van Cutsem
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (17): 3686–3694.
https://doi.org/10.1158/1078-0432.CCR-21-4021
Published: 02 September 2022
View article titled, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Open the PDF for Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

Abstract PO001: Preclinical activity of glypican-3 (GPC3) and NKp46 directed FLEX-NK™ engager antibody (CYT-303) in combination with iPSC derived natural killer cells (iNKs) or peripheral blood (PB) NK cells in hepatocellular carcinoma (HCC)

Antonio Arulanandam, Liang Lin, Hao-Ming Chang, Harish Potu, Vishal Khairnar, David Zou, Melissa Triggiano, Nejmi Dilmac, Yinan Yang, Shira Kahlon, Stanley Frankel, Jean Kadouche, Daniel Teper, Ofer Mandelboim, Yoav Hershkovitz, Yaron Ilan, Wei Li
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (17_Supplement): PO001.
https://doi.org/10.1158/1557-3265.LIVERCA22-PO001
Published: 01 September 2022
View article titled, Abstract PO001: Preclinical activity of glypican-3 (GPC3) and NKp46 directed FLEX-NK™ engager antibody (CYT-303) in combination with iPSC derived natural killer cells (iNKs) or peripheral blood (PB) NK cells in hepatocellular carcinoma (HCC)
Journal Articles

Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker Analysis

Yuqin Song, Quanli Gao, Huilai Zhang, Lei Fan, Jianfeng Zhou, Dehui Zou, Wei Li, Haiyan Yang, Ting Liu, Quanshun Wang, Fangfang Lv, Haiyi Guo, Xia Zhao, Dan Wang, Pei Zhang, Yidi Wang, Lei Wang, Tengfei Liu, Yun Zhang, Zhirong Shen, Jane Huang, Jun Zhu
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (6): 1147–1156.
https://doi.org/10.1158/1078-0432.CCR-21-2023
Published: 15 March 2022
View article titled, Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker Analysis
Open the PDF for Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker Analysis in another window
Includes: Supplementary data
Journal Articles

EpiPanGI Dx: A Cell-free DNA Methylation Fingerprint for the Early Detection of Gastrointestinal Cancers

Raju Kandimalla, Jianfeng Xu, Alexander Link, Takatoshi Matsuyama, Kensuke Yamamura, M. Iqbal Parker, Hiroyuki Uetake, Francesc Balaguer, Erkut Borazanci, Susan Tsai, Douglas Evans, Stephen J. Meltzer, Hideo Baba, Randall Brand, Daniel Von Hoff, Wei Li, Ajay Goel
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (22): 6135–6144.
https://doi.org/10.1158/1078-0432.CCR-21-1982
Published: 15 November 2021
View article titled, EpiPanGI Dx: A Cell-free DNA Methylation Fingerprint for the Early Detection of Gastrointestinal Cancers
Open the PDF for EpiPanGI Dx: A Cell-free DNA Methylation Fingerprint for the Early Detection of Gastrointestinal Cancers in another window
Includes: Supplementary data
Journal Articles

A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer

Wei-Xiong Xia, Xing Lv, Hu Liang, Guo-Ying Liu, Rui Sun, Qi Zeng, Si-Wei Li, Hao-Yuan Mo, Fei Han, Dong-Hua Luo, Qing Liu, Meng-Yun Shi, Yan-Fang Ye, Jing Yang, Liang-Ru Ke, Meng-Yun Qiang, Wen-Ze Qiu, Ya-Hui Yu, Kui-Yuan Liu, Xin-Jun Huang, Wang-Zhong Li, Shu-Hui Lv, Zhuo-Chen Cai, Jing-Jing Miao, Ling Guo, Ming-Yuan Chen, Ka-Jia Cao, Lin Wang, Chong Zhao, Pei-Yu Huang, Qiu-Yan Chen, Yi-Jun Hua, Lin-Quan Tang, Chao-Nan Qian, Hai-Qiang Mai, Xiang Guo, Yan-Qun Xiang
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (15): 4186–4194.
https://doi.org/10.1158/1078-0432.CCR-20-4532
Published: 01 August 2021
View article titled, A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer
Open the PDF for A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer in another window
Includes: Supplementary data
Journal Articles

Biomarkers of Osimertinib Response in Patients with Refractory, EGFR-T790M–positive Non–Small Cell Lung Cancer and Central Nervous System Metastases: The APOLLO Study

Ligang Xing, Yueyin Pan, Yuankai Shi, Yongqian Shu, Jifeng Feng, Wei Li, Lejie Cao, Lifeng Wang, Wei Gu, Yong Song, Puyuan Xing, Yutao Liu, Wen Gao, Jiuwei Cui, Nana Hu, Rutian Li, Hua Bao, Yang Shao, Jinming Yu
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (23): 6168–6175.
https://doi.org/10.1158/1078-0432.CCR-20-2081
Published: 01 December 2020
View article titled, Biomarkers of Osimertinib Response in Patients with Refractory, EGFR-T790M–positive Non–Small Cell Lung Cancer and Central Nervous System Metastases: The APOLLO Study
Open the PDF for Biomarkers of Osimertinib Response in Patients with Refractory, EGFR-T790M–positive Non–Small Cell Lung Cancer and Central Nervous System Metastases: The APOLLO Study in another window
Includes: Supplementary data
Journal Articles

A CpG Methylation Classifier to Predict Relapse in Adults with T-Cell Lymphoblastic Lymphoma

Xiao-Peng Tian, Ning Su, Liang Wang, Wei-Juan Huang, Yan-Hui Liu, Xi Zhang, Hui-Qiang Huang, Tong-Yu Lin, Shu-Yun Ma, Hui-Lan Rao, Mei Li, Fang Liu, Fen Zhang, Li-Ye Zhong, Li Liang, Xiao-Liang Lan, Juan Li, Bing Liao, Zhi-Hua Li, Qiong-Lan Tang, Qiong Liang, Chun-Kui Shao, Qiong-Li Zhai, Run-Fen Cheng, Qi Sun, Kun Ru, Xia Gu, Xi-Na Lin, Kun Yi, Yue-Rong Shuang, Xiao-Dong Chen, Wei Dong, Cai Sun, Wei Sang, Hui Liu, Zhi-Gang Zhu, Jun Rao, Qiao-Nan Guo, Ying Zhou, Xiang-Ling Meng, Yong Zhu, Chang-Lu Hu, Yi-Rong Jiang, Ying Zhang, Hong-Yi Gao, Wen-Jun He, Zhong-Jun Xia, Xue-Yi Pan, Lan Hai, Guo-Wei Li, Li-Yan Song, Tie-Bang Kang, Dan Xie, Qing-Qing Cai
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (14): 3760–3770.
https://doi.org/10.1158/1078-0432.CCR-19-4207
Published: 15 July 2020
View article titled, A CpG Methylation Classifier to Predict Relapse in Adults with T-Cell Lymphoblastic Lymphoma
Open the PDF for A CpG Methylation Classifier to Predict Relapse in Adults with T-Cell Lymphoblastic Lymphoma in another window
Includes: Supplementary data
Journal Articles

Randomized Trial of Intermediate-dose Cytarabine in Induction and Consolidation Therapy in Adults with Acute Myeloid Leukemia

Hui Wei, Ying Wang, Robert Peter Gale, Dong Lin, Chunlin Zhou, Bingcheng Liu, Shaowei Qiu, Runxia Gu, Yan Li, Xingli Zhao, Shuning Wei, Benfa Gong, Kaiqi Liu, Xiaoyuan Gong, Yuntao Liu, Guangji Zhang, Zhen Song, Yang Wang, Wei Li, Yingchang Mi, Jianxiang Wang
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (13): 3154–3161.
https://doi.org/10.1158/1078-0432.CCR-19-3433
Published: 01 July 2020
View article titled, Randomized Trial of Intermediate-dose Cytarabine in Induction and Consolidation Therapy in Adults with Acute Myeloid Leukemia
Open the PDF for Randomized Trial of Intermediate-dose Cytarabine in Induction and Consolidation Therapy in Adults with Acute Myeloid Leukemia in another window
Includes: Supplementary data
Journal Articles

Clinical Efficacy and Tumor Microenvironment Influence in a Dose-Escalation Study of Anti-CD19 Chimeric Antigen Receptor T Cells in Refractory B-Cell Non-Hodgkin's Lymphoma

Zi-Xun Yan, Li Li, Wen Wang, Bin-Shen OuYang, Shu Cheng, Li Wang, Wen Wu, Peng-Peng Xu, Muharrem Muftuoglu, Ming Hao, Su Yang, Mu-Chen Zhang, Zhong Zheng, James Li, Wei-Li Zhao
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (23): 6995–7003.
https://doi.org/10.1158/1078-0432.CCR-19-0101
Published: 02 December 2019
View article titled, Clinical Efficacy and Tumor Microenvironment Influence in a Dose-Escalation Study of Anti-CD19 Chimeric Antigen Receptor T Cells in Refractory B-Cell Non-Hodgkin's Lymphoma
Open the PDF for Clinical Efficacy and Tumor Microenvironment Influence in a Dose-Escalation Study of Anti-CD19 Chimeric Antigen Receptor T Cells in Refractory B-Cell Non-Hodgkin's Lymphoma in another window
Includes: Supplementary data
Journal Articles

FLI1 Exonic Circular RNAs as a Novel Oncogenic Driver to Promote Tumor Metastasis in Small Cell Lung Cancer

Lingyu Li, Wei Li, Naifei Chen, Haixin Zhao, Guang Xu, Yijing Zhao, Xin Pan, Xiaoying Zhang, Lei Zhou, Dehai Yu, Ailing Li, Ji-Fan Hu, Jiuwei Cui
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (4): 1302–1317.
https://doi.org/10.1158/1078-0432.CCR-18-1447
Published: 15 February 2019
View article titled, <em>FLI1</em> Exonic Circular RNAs as a Novel Oncogenic Driver to Promote Tumor Metastasis in Small Cell Lung Cancer
Open the PDF for <em>FLI1</em> Exonic Circular RNAs as a Novel Oncogenic Driver to Promote Tumor Metastasis in Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression

Shiping Jiao, Weiya Xia, Hirohito Yamaguchi, Yongkun Wei, Mei-Kuang Chen, Jung-Mao Hsu, Jennifer L. Hsu, Wen-Hsuan Yu, Yi Du, Heng-Huan Lee, Chia-Wei Li, Chao-Kai Chou, Seung-Oe Lim, Shih-Shin Chang, Jennifer Litton, Banu Arun, Gabriel N. Hortobagyi, Mien-Chie Hung
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (14): 3711–3720.
https://doi.org/10.1158/1078-0432.CCR-16-3215
Published: 13 July 2017
View article titled, PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression
Open the PDF for PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression in another window
Includes: Multimedia, Supplementary data
Journal Articles

Gleason Score 7 Prostate Cancers Emerge through Branched Evolution of Clonal Gleason Pattern 3 and 4

Adam G. Sowalsky, Haydn T. Kissick, Sean J. Gerrin, Rachel J. Schaefer, Zheng Xia, Joshua W. Russo, M. Simo Arredouani, Glenn J. Bubley, Martin G. Sanda, Wei Li, Huihui Ye, Steven P. Balk
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (14): 3823–3833.
https://doi.org/10.1158/1078-0432.CCR-16-2414
Published: 13 July 2017
View article titled, Gleason Score 7 Prostate Cancers Emerge through Branched Evolution of Clonal Gleason Pattern 3 and 4
Open the PDF for Gleason Score 7 Prostate Cancers Emerge through Branched Evolution of Clonal Gleason Pattern 3 and 4 in another window
Includes: Supplementary data
Journal Articles

Severe Hepatitis Promotes Hepatocellular Carcinoma Recurrence via NF-κB Pathway-Mediated Epithelial–Mesenchymal Transition after Resection

Ting-Jung Wu, Shih-Shin Chang, Chia-Wei Li, Yi-Hsin Hsu, Tse-Ching Chen, Wei-Chen Lee, Chau-Ting Yeh, Mien-Chie Hung
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (7): 1800–1812.
https://doi.org/10.1158/1078-0432.CCR-15-0780
Published: 31 March 2016
View article titled, Severe Hepatitis Promotes Hepatocellular Carcinoma Recurrence via NF-κB Pathway-Mediated Epithelial–Mesenchymal Transition after Resection
Open the PDF for Severe Hepatitis Promotes Hepatocellular Carcinoma Recurrence via NF-κB Pathway-Mediated Epithelial–Mesenchymal Transition after Resection in another window
Includes: Supplementary data
Journal Articles

Mammaglobin: a specific molecular target for immune based breast cancer therapy

Wei Li, Ningxi Zhu, Qian Wang, Timothy P. Fleming, Shaojin You
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (19_Supplement): B30.
Published: 15 August 2014
View article titled, Mammaglobin: a specific molecular target for immune based breast cancer therapy
Journal Articles

Sonic Hedgehog Paracrine Signaling Activates Stromal Cells to Promote Perineural Invasion in Pancreatic Cancer

Xuqi Li, Zheng Wang, Qingyong Ma, Qinhong Xu, Han Liu, Wanxing Duan, Jianjun Lei, Jiguang Ma, Xiu Wang, Shifang Lv, Liang Han, Wei Li, Jian Guo, Kun Guo, Dong Zhang, Erxi Wu, Keping Xie
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (16): 4326–4338.
https://doi.org/10.1158/1078-0432.CCR-13-3426
Published: 13 August 2014
View article titled, Sonic Hedgehog Paracrine Signaling Activates Stromal Cells to Promote Perineural Invasion in Pancreatic Cancer
Open the PDF for Sonic Hedgehog Paracrine Signaling Activates Stromal Cells to Promote Perineural Invasion in Pancreatic Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract B09: Multiplexed mass spectrometry-based assay to quantify translocation markers from non-small cell lung cancer (NSCLC) FFPE tissue.

Wei-Li Liao, Sheeno Thyparambil, Eunkyung An, Christopher P. Hartley, patrick Ma, Jaime Rodriguez, Ignacio Wistuba, Jon Burrows, Todd Hembrough, Laura J. Tafe
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (2_Supplement): B09.
https://doi.org/10.1158/1078-0432.14AACRIASLC-B09
Published: 16 January 2014
View article titled, Abstract B09: Multiplexed mass spectrometry-based assay to quantify translocation markers from non-small cell lung cancer (NSCLC) FFPE tissue.
Journal Articles

Abstract A24: Development and clinical validation of a quantitative mass spectrometric assay for PD-L1 protein in FFPE NSCLC samples.

Eunkyung An, Wei-Li Liao, Sheeno Thyparambil, Jaime Rodriguez, Ravi Salgia, Ignacio I. Wistuba, Jon Burrows, Todd Hembrough
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (2_Supplement): A24.
https://doi.org/10.1158/1078-0432.14AACRIASLC-A24
Published: 16 January 2014
View article titled, Abstract A24: Development and clinical validation of a quantitative mass spectrometric assay for PD-L1 protein in FFPE NSCLC samples.
Journal Articles

Abstract A50: Development of a quantitative RON SRM Assay for use in formalin fixed tumor tissues

Todd Hembrough, Wei-Li Liao, Les Henderson, Peng Xu, Jon Burrows, Daniel Catenacci
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (10_Supplement): A50.
https://doi.org/10.1158/1078-0432.MECHRES-A50
Published: 04 March 2013
View article titled, Abstract A50: Development of a quantitative RON SRM Assay for use in formalin fixed tumor tissues
Open the PDF for Abstract A50: Development of a quantitative RON SRM Assay for use in formalin fixed tumor tissues in another window
Journal Articles

Establishment and Characterization of Novel Cell Lines from Sinonasal Undifferentiated Carcinoma

Yoko Takahashi, Michael E. Kupferman, Diana Bell, Tilahun Jiffar, June Goo Lee, Tong-Xin Xie, Ning-Wei Li, Mei Zhao, Mitchell J. Frederick, Alexander Gelbard, Jeffrey N. Myers, Ehab Y. Hanna
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (22): 6178–6187.
https://doi.org/10.1158/1078-0432.CCR-12-1876
Published: 14 November 2012
View article titled, Establishment and Characterization of Novel Cell Lines from Sinonasal Undifferentiated Carcinoma
Open the PDF for Establishment and Characterization of Novel Cell Lines from Sinonasal Undifferentiated Carcinoma in another window
Includes: Supplementary data